Navigation Links
The U.S. Biochip Products and Services Market is Expected to Reach USD 4.7 Billion in 2018: Transparency Market Research

ALBANY, New York, May 21, 2013 /PRNewswire/ --

According to a new market report published by Transparency Market Research ( "Biochip Products and Services Market (Microarrays, Reagents, Drug Discovery, Life Science Research, IVD Tests) - U.S. Industry Analysis, Size, Share, Growth, Trends and Forecast, 2012 - 2018," the market was valued at USD 2.4 billion in 2011 and is expected to grow at a CAGR of 10.1% from 2012 to 2018, to reach an estimated value of USD 4.7 billion in 2018.

Browse the full report at

The most important growth driver of this market is the increasing application of genomics and proteomics in cancer treatment research, leading to an increase in the use of microarrays and reagents. Furthermore, growth in drug discovery, personalized medicine and life science research, along with developments such as the U.S. FDA approval of personalized medicines for treatment of melanoma and lung cancer will also support future growth of this market.

Microarrays held the majority share of the total market in 2011, on account of technological advancements in the field of microarrays and increased commercial application of biochips post the success of the Human Genome Project (HGP). Within this segment, the highest market share is held by DNA chips, due to increasing gene expression profiling in drug delivery and epidemiological research. The laboratory and protein chip segments are expected to experience maximum growth within the microarrays segment, due to product advancements and broadening capabilities in drug delivery and diagnostic testing. The market for reagents and other consumables holds the potential for highest growth; it is expected to grow at a CAGR of 10.7% from 2012 to 2018, due to the need for higher quality of sample preparation, and labeling and purification agents.

Related & Recently Published Reports by Transparency Market Research

Drug delivery held the highest market share by application in 2011, at over 50%, on account of the increased use of biochip technology in gene expression analysis, single nucleotide polymorphism (SNP) identification and genotyping, protein analysis and characterization in drug delivery. The market for other applications including disease management, forensic medicine, military and defense applications, and agriculture, will witness the highest growth rate during the forecast period.

Related & Recently Published Reports by Transparency Market Research

The key market players in the U.S. biochip market are Affymetrix, Inc., Life Technologies Corporation and Illumina, Inc. Other important market players include Becton, Dickinson and Company and Agilent Technologies. The market witnesses low product differentiation, and increasing strategic alliances and collaborative developments.

The U.S. biochip market is categorized into the following segments:

  • Biochip Market, by Segments
    • Biochip Products Market
    • Biochip Services Market
  • Biochip Products Market, by Types
    • Microarrays
    • Reagents and Other Consumables
    • Others (Biochip Instruments and Software)
  • Biochip Products and Services Market, by Applications
    • Drug Delivery
    • Life Science Research
    • In Vitro Diagnostic Testing
    • Others (Disease Management, Forensic Medicine, Defense)

Browse all Medical Devices Market Research Reports@

Upcoming Reports in Medical Devices Market

Healthcare Microchip Array Market

Oncology Devices Market

Radiation Detection, Monitoring and Safety Market

PreClinical Imaging Market

Digital Radiology Market

Diagnostic Electrocardiograph (DECG) Market

Medical Plastics Market

Nanomedical Devices and Therapeutics Market

Medical Bionic Implant Market

Endoscopy Devices Market

About Us

Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. We are privileged with highly experienced team of Analysts, Researchers, and Consultants, who use proprietary data sources and various tools and techniques to gather, and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

Sheela AK
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453

SOURCE Transparency Market Research
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Global Biochips and Microarrays 2013 Market Report
2. New Guide to Kill Bed Bugs Published by My Cleaning Products, Company Enumerates Non-Toxic Means to Clear the Pests
3. Revolutionary Science Announces New Automatic and Manual Colony Counting Products
4. Possible Mold Re-infestation Gets Guilmette School Scheduled for Re-inspection, My Cleaning Products Offers Tip How to Kill Mold Safely If Inspection Turns Positive
5. New Non Pesticide Discovery on How to Get Rid of Bed Bugs Tipped by My Cleaning Products
6. Pharmacists' Picks: Topical BioMedics' Topricin Listed on Top Recommended OTC Health Products
7. New Temperature Control Products Announced by Oven Industries Inc.
8. Aridis Pharmaceuticals Announces Acquisition of Monoclonal Antibody Products and Technologies From Kenta Biotech
9. Organic-Based Rust Remover Cuts Down Price by 10%, My Cleaning Products Details Mechanics How to Get the Discount
10. Bed Bugs Plague Tarpon Springs Apartment Complex, Non-Pesticide Bed Bug Spray Recommended to Management by My Cleaning Products to Help
11. Bed Bug Treatment Cost Leaves Tenant No Choice But to Move, My Cleaning Products Offers Aid How to Get Rid of Bed Bugs Without Spending Big
Post Your Comments:
(Date:10/13/2015)... ... October 13, 2015 , ... The ... school age children in the areas of Science, Technology, Engineering and Mathematics. The ... national economy, and the program aims to increase the number of students who ...
(Date:10/12/2015)... South Carolina (PRWEB) , ... October 12, 2015 , ... ... to announce the release of the CSM-C 600 compact clean steam generator . ... saturated steam that meets the requirements of HTM2031, HTM2010, and EN285 standards. The ...
(Date:10/12/2015)... , Oct. 12, 2015  Rebiotix Inc. today ... has designated its lead Microbiota Restoration Therapy (MRT) ... of recurrent Clostridium difficile (C diff) ... that causes 29,000 deaths in the U.S. annually. ... company that was founded to revolutionize the treatment ...
(Date:10/12/2015)... , Oct. 12, 2015 /PRNewswire/ - Aeterna Zentaris ... biopharmaceutical company engaged in developing and commercializing novel treatments ... departure of Dennis Turpin , the Company,s former ... to close its Quebec City ... President and Chief Executive Officer of the Company commented, ...
Breaking Biology Technology:
(Date:10/6/2015)... 2015 Track Group, Inc. (OTCQX: TRCK), a ... signed a contract with the Virginia Department of Corrections ... of sentences under the Department,s oversight. Derek ... contract with the Virginia DOC will expand our footprint ... our position as a trusted leader in offender electronic ...
(Date:10/2/2015)... 02 2015 ... "Enforcing the Law Using Biometrics" report to ... announced the addition of the "Enforcing the ... --> Research and Markets ( ... "Enforcing the Law Using Biometrics" report to ...
(Date:9/30/2015)... 2015  The U.S. Court of Appeals for the ... in favor of Crossmatch ™, affirming the International ... Suprema and its U.S. partner Mentalix violated Section 337 ... that declares it unlawful to engage in "unfair practices" ... Crossmatch,s patents, the 5,900,993 patent and the 7,203,344 patent. ...
Breaking Biology News(10 mins):